Exercise
BehavioralMorning concurrent high-intensity interval training and resistance training
NCT Number: NCT07630025
The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. The main questions it aims to answer are:
• Which time is best for concurrent exercise training in diabetic patients, morning or evening? Researchers will compare morning versus evening concurrent training consisting of HIIT and RT on glycemic control in men with type 2 diabetes mellitus.
Participants will:
* Perform concurrent training consisting of high-intensity interval training and resistance training for 12 weeks * Visit the clinic before and after the 12-week experimental period for checkups and tests
Trial opening soon.
Get Notified40 year–60 year
Male
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Morning concurrent high-intensity interval training and resistance training
Time frame: baseline and at 12 weeks.
HbA1c
Time frame: baseline and at 12 weeks
total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides
Time frame: at baseline and at 12 weeks
VO2peak
Prince Sattam Bin Abdulaziz University
Other
The Impact of Morning Versus Evening Concurrent High-Intensity Interval Training and Resistance Training on Glycemic Control in in Men With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Acronym: T2D
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07417683
Body Weight, MASH
Mannheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT07388537
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT07313787
Diabetes, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT06645769
Diabetes, Diabetes Mellitus
View Trial Details